SCHEMBL4505147

SCHEMBL4505147

O=C(Nc1ccc(Cn2cccn2)cc1)c1cc(COc2cc(Cl)ccc2Cl)ccn1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 8/20 0.55
HPGD P15428 5/20 0.55
MAPT P10636 4/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
LMNA P02545 2/20 0.55
NPC1 O15118 3/20 0.51
RAB9A P51151 3/20 0.51
KDM4E B2RXH2 1/20 0.51
GAA P10253 1/20 0.51
F2 P00734 1/20 0.49
F10 P00742 1/20 0.49
CYP1A2 P05177 2/20 0.47
CYP3A4 P08684 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
CYP2D6 P10635 1/20 0.47
TDP1 Q9NUW8 1/20 0.44
THRB P10828 1/20 0.43
GRM4 Q14833 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4509290 0.91 MAPT (0.56) SMN1; SMN2HPGDMAPTMEN1KMT2A
SCHEMBL4503513 0.91 SMN1; SMN2 (0.62) SMN1; SMN2HPGDMAPTMEN1KMT2A
SCHEMBL4509295 0.88 SMN1; SMN2 (0.60) SMN1; SMN2HPGDMAPTMEN1KMT2A
SCHEMBL4505158 0.86 MAPT (0.64) SMN1; SMN2HPGDMAPTMEN1KMT2A
SCHEMBL4502628 0.85 SMN1; SMN2 (0.51) SMN1; SMN2HPGDMAPTMEN1KMT2A
SCHEMBL4506465 0.85 SMN1; SMN2 (0.56) SMN1; SMN2HPGDMAPTMEN1KMT2A
SCHEMBL4518670 0.85 MAPT (0.56) SMN1; SMN2HPGDMAPTMEN1KMT2A
SCHEMBL4517237 0.84 MAPT (0.61) SMN1; SMN2HPGDMAPTMEN1KMT2A
SCHEMBL4504870 0.81 SMN1; SMN2 (0.52) SMN1; SMN2HPGDMAPTMEN1KMT2A
SCHEMBL4505607 0.80 SMN1; SMN2 (0.43) SMN1; SMN2HPGDMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090325956-A1 Aromatic amine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325956-A1 Aromatic amine derivative and use thereof SCD, SCD5, SMS SMN1; SMN2 2075/4885HPGD 1447/4885MAPT 4022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.